We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$110B
AUM Growth
+$10.8B
Cap. Flow
+$4.52B
Cap. Flow %
4.11%
Top 10 Hldgs %
23.63%
Holding
4,320
New
332
Increased
2,194
Reduced
1,423
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 14.49%
2 Financials 8.91%
3 Healthcare 8.14%
4 Industrials 6.57%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LFUS icon
1151
Littelfuse
LFUS
$11.6B
$8.69M 0.01%
34,109
-910
-3% -$237K
CUZ icon
1152
Cousins Properties
CUZ
$4.83B
$8.69M 0.01%
236,258
+111,230
+89% +$4.09M
TXRH icon
1153
Texas Roadhouse
TXRH
$13.6B
$8.69M 0.01%
90,285
+22,920
+34% +$2.26M
CNXC icon
1154
Concentrix
CNXC
$1.56B
$8.68M 0.01%
53,991
-13,709
-20% -$2.11M
MSA icon
1155
Mine Safety
MSA
$7.45B
$8.65M 0.01%
52,230
-1,307
-2% -$212K
PUK icon
1156
Prudential
PUK
$35.1B
$8.64M 0.01%
233,883
-239,124
-51% -$9.79M
VRT icon
1157
Vertiv
VRT
$104B
$8.63M 0.01%
316,185
-4,634
-1% -$111K
NICE icon
1158
Nice
NICE
$6.01B
$8.61M 0.01%
34,795
+566
+2% +$130K
ZD icon
1159
Ziff Davis
ZD
$2B
$8.6M 0.01%
71,916
-8,418
-10% -$925K
TRNO icon
1160
Terreno Realty
TRNO
$7.45B
$8.59M 0.01%
133,069
+37,906
+40% +$2.41M
IFF icon
1161
International Flavors & Fragrances
IFF
$21.7B
$8.56M 0.01%
57,310
+12,216
+27% +$1.75M
GNTX icon
1162
Gentex
GNTX
$5.02B
$8.54M 0.01%
258,044
+14,763
+6% +$512K
UNM icon
1163
Unum
UNM
$14.5B
$8.53M 0.01%
300,485
+30,700
+11% +$902K
K
1164
DELISTED
Kellanova
K
$8.53M 0.01%
141,225
-22,274
-14% -$1.35M
ITRI icon
1165
Itron
ITRI
$4.49B
$8.53M 0.01%
85,296
+36,423
+75% +$3.38M
KBH icon
1166
KB Home
KBH
$3.47B
$8.53M 0.01%
209,375
-10,451
-5% -$482K
IYT icon
1167
iShares US Transportation ETF
IYT
$2.27B
$8.51M 0.01%
130,936
-164
-0.1% -$11K
USFR
1168
DELISTED
WisdomTree Bloomberg Floating Rate Treasury Fund
USFR
$8.51M 0.01%
338,928
+10,810
+3% +$271K
VIOO icon
1169
Vanguard S&P Small-Cap 600 ETF
VIOO
$4.3B
$8.49M 0.01%
81,888
+3,494
+4% +$357K
HQY icon
1170
HealthEquity
HQY
$8.93B
$8.49M 0.01%
105,502
+12,169
+13% +$927K
SPGP icon
1171
Invesco S&P 500 GARP ETF
SPGP
$2.32B
$8.42M 0.01%
96,016
+44,312
+86% +$3.79M
HOG icon
1172
Harley-Davidson
HOG
$2.72B
$8.41M 0.01%
183,645
-7,625
-4% -$354K
OGE icon
1173
OGE Energy
OGE
$9.54B
$8.41M 0.01%
249,905
+5,071
+2% +$171K
E icon
1174
ENI
E
$79.4B
$8.39M 0.01%
343,904
+125,883
+58% +$3.14M
LADR
1175
Ladder Capital
LADR
$1.22B
$8.38M 0.01%
725,895
-7,598
-1% -$89.1K

Similar funds

Raymond James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Raymond James & Associates held 4,320 positions worth $110B, up 11% from $99.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.52B of net new capital in Q2 2021, opening 332 new positions and adding to 2,194 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $175M trimmed.

  • Raymond James & Associates's largest Q2 2021 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $290M increase.
  • Raymond James & Associates's biggest Q2 2021 reduction was Amgen, cutting an estimated $175M.
  • Raymond James & Associates fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $19.1M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $110B portfolio in Q2 2021.
  • Raymond James & Associates opened 332 new positions and closed 241 in Q2 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.